Profile data is unavailable for this security.
About the company
Ainos, Inc. is a diversified healthcare company, which is focused on the development of point-of-care testing (POCT), low-dose VELDONA interferon therapeutics and synthetic Ribonucleic Acid (RNA)-driven preventative medicine. The Company's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza, Sjogrens syndrome and treatment for mild COVID-19 symptoms.
- Revenue in USD (TTM)65.12k
- Net income in USD-15.41m
- Incorporated1984
- Employees46.00
- LocationAinos Inc8880 Rio San Diego Drive, Ste. 800SAN DIEGO 92108United StatesUSA
- Phone+1 (858) 869-2986
- Websitehttps://www.ainos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNF Pharmaceuticals Inc | 0.00 | -7.07m | 3.60m | 9.00 | -- | 0.1548 | -- | -- | -5.53 | -5.53 | 0.00 | 10.28 | 0.00 | -- | -- | 0.00 | -25.59 | -76.20 | -31.13 | -84.38 | -- | 7.64 | -- | -4,290.96 | -- | -- | 0.00 | -- | -- | -- | 49.15 | -- | -- | -- |
| Artelo Biosciences Inc | 0.00 | -10.44m | 3.60m | 5.00 | -- | 0.4931 | -- | -- | -3.33 | -3.33 | 0.00 | 2.26 | 0.00 | -- | -- | 0.00 | -82.83 | -- | -88.23 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.87 | -- | -- | -- |
| Bone Biologics Corp | 0.00 | -5.12m | 3.61m | 2.00 | -- | 0.7778 | -- | -- | -10.26 | -10.26 | 0.00 | 2.21 | 0.00 | -- | -- | 0.00 | -94.66 | -98.31 | -119.03 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
| Hepion Pharmaceuticals Inc | 0.00 | -28.37m | 3.62m | 22.00 | -- | 1.94 | -- | -- | -6.49 | -6.49 | 0.00 | 0.6142 | 0.00 | -- | -- | 0.00 | -133.45 | -61.43 | -167.53 | -68.82 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.92 | -- | -- | -- |
| Chromocell Therapeutics Corp | 0.00 | -8.98m | 3.63m | 4.00 | -- | 3.21 | -- | -- | -1.66 | -1.66 | 0.00 | 0.196 | 0.00 | -- | -- | 0.00 | -440.01 | -- | -- | -- | -- | -- | -- | -- | -- | -7.20 | 0.00 | -- | -- | -- | -200.20 | -- | -- | -- |
| Notable Labs Ltd | 313.00k | -16.74m | 3.72m | 16.00 | -- | 0.5175 | -- | 11.88 | -2.47 | -2.47 | 0.046 | 0.7439 | 0.0176 | -- | -- | 19,562.50 | -93.89 | -52.02 | -120.26 | -62.09 | 37.70 | 60.19 | -5,346.97 | -3,636.93 | -- | -- | 0.0405 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
| Enveric Biosciences Inc | 0.00 | -10.59m | 3.73m | 7.00 | -- | 0.6102 | -- | -- | -3.67 | -3.67 | 0.00 | 0.6862 | 0.00 | -- | -- | 0.00 | -133.67 | -104.94 | -206.10 | -156.88 | -- | -- | -- | -243.54 | -- | -- | 0.00 | -- | -- | -- | 7.14 | -- | -- | -- |
| Theriva Biologics Inc | 0.00 | -22.27m | 3.75m | 21.00 | -- | 1.43 | -- | -- | -1.25 | -1.25 | 0.00 | 1.23 | 0.00 | -- | -- | 0.00 | -41.30 | -36.95 | -48.49 | -40.16 | -- | -- | -- | -- | -- | -- | 0.0056 | -- | -- | -- | 8.37 | -- | 95.91 | -- |
| CTT Pharmaceutical Holdings Inc | 0.00 | -1.67m | 3.75m | 0.00 | -- | 2.02 | -- | -- | -0.0822 | -0.0822 | 0.00 | 0.0346 | 0.00 | -- | -- | -- | -317.28 | 13.49 | -448.83 | 304.48 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3,454.52 | -- | -- | -- |
| Azitra Inc | 408.20k | -9.96m | 3.81m | 10.00 | -- | 0.2779 | -- | 9.33 | -12.12 | -12.12 | 0.1151 | 1.80 | 0.0595 | -- | 1.83 | 40,820.00 | -145.30 | -- | -194.72 | -- | -- | -- | -2,440.46 | -- | -- | -- | 0.0191 | -- | 141.55 | -- | 6.02 | -- | -- | -- |
| Synaptogenix Inc | 0.00 | -3.45m | 3.88m | 5.00 | -- | 0.1969 | -- | -- | -3.89 | -3.89 | 0.00 | 14.99 | 0.00 | -- | -- | 0.00 | -5.54 | -40.33 | -6.89 | -43.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -142.17 | -- | -3.21 | -- |
| Ainos Inc | 65.12k | -15.41m | 3.88m | 46.00 | -- | 0.1719 | -- | 59.55 | -3.17 | -3.17 | 0.0126 | 2.80 | 0.0019 | 0.7814 | 13.86 | 1,415.65 | -44.29 | -36.36 | -49.13 | -58.33 | -316.62 | 36.82 | -23,664.28 | -813.63 | 1.45 | -55.50 | 0.4016 | -- | -96.53 | 9.46 | 1.69 | -- | 66.44 | -- |
| CNS Pharmaceuticals Inc | 0.00 | -15.97m | 3.94m | 3.00 | -- | -- | -- | -- | -134.04 | -134.04 | 0.00 | -2.97 | 0.00 | -- | -- | 0.00 | -358.12 | -132.47 | -- | -185.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.42 | -- | -- | -- |
| Palisade Bio Inc | 0.00 | -14.17m | 3.99m | 9.00 | -- | 0.3274 | -- | -- | -20.07 | -20.07 | 0.00 | 10.30 | 0.00 | -- | -- | 0.00 | -90.97 | -132.36 | -109.07 | -165.45 | -- | -- | -- | -27,892.32 | -- | -972.73 | 0.0339 | -- | -- | -0.7814 | 13.74 | -- | 18.53 | -- |
| Lixte Biotechnology Holdings Inc | 0.00 | -4.03m | 4.00m | 3.00 | -- | -- | -- | -- | -1.83 | -1.83 | 0.00 | 0.9986 | 0.00 | -- | -- | 0.00 | -139.98 | -104.18 | -163.33 | -111.05 | -- | -- | -- | -- | -- | -563.88 | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
| Galera Therapeutics Inc | 0.00 | -29.11m | 4.03m | 7.00 | -- | -- | -- | -- | -0.5892 | -0.5892 | 0.00 | -2.54 | 0.00 | -- | -- | 0.00 | -90.03 | -83.69 | -119.01 | -97.54 | -- | -- | -- | -- | -- | -14.34 | 11.60 | -- | -- | -- | 5.05 | -- | -29.84 | -- |
Data as of Oct 09 2024. Currency figures normalised to Ainos Inc's reporting currency: US Dollar USD
1.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Two Sigma Securities LLCas of 31 Mar 2024 | 25.59k | 0.39% |
| Geode Capital Management LLCas of 30 Jun 2024 | 20.36k | 0.31% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 15.33k | 0.24% |
| Virtu Americas LLCas of 30 Jun 2024 | 13.15k | 0.20% |
| G1 Execution Services LLCas of 31 Mar 2024 | 12.63k | 0.19% |
| UBS Securities LLCas of 31 Mar 2024 | 11.48k | 0.18% |
| Tower Research Capital LLCas of 31 Mar 2024 | 8.47k | 0.13% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 15.00 | 0.00% |
| CWM LLCas of 30 Jun 2024 | 7.00 | 0.00% |
| Arbor Point Advisors LLCas of 31 Mar 2024 | 3.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
